GLA Gene Fabry Disease Genetic Test
At DNA Labs UAE, we offer the GLA Gene Fabry disease genetic test for individuals who suspect they may have Fabry disease. This diagnostic test helps identify mutations in the GLA gene associated with Fabry disease. Fabry disease is a rare genetic disorder characterized by the buildup of a fatty substance called globotriaosylceramide (GL-3) in various tissues and organs, resulting in a range of symptoms.
Test Components and Price
- Test Name: GLA Gene Fabry disease Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
Test Method and Type
The GLA Gene Fabry disease genetic test utilizes Next-generation sequencing (NGS) technology. NGS allows for the analysis of the DNA sequence of the GLA gene, enabling the detection of mutations or variations that may be responsible for causing Fabry disease. This high-throughput sequencing method can analyze multiple genes simultaneously, making it a comprehensive and efficient approach to genetic testing. The test type is specifically designed for the diagnosis of metabolic disorders.
Test Department and Doctor
The GLA Gene Fabry disease genetic test is performed in our Genetics department by our team of experienced General Physicians. Our doctors are qualified healthcare professionals who specialize in genetic testing and interpretation.
Pre-Test Information
Prior to undergoing the GLA Gene Fabry disease genetic test, it is recommended to provide the clinical history of the patient. Additionally, a Genetic Counselling session is conducted to draw a pedigree chart of family members affected with Fabry disease. This helps in assessing the likelihood of the gene mutation in the family.
Test Details
The GLA Gene Fabry disease genetic test is typically conducted using a blood or saliva sample. The sample is sent to our specialized laboratory where the DNA is extracted and sequenced using NGS technology. The resulting DNA sequence data is then analyzed to identify any mutations or variations in the GLA gene. This information is compiled into a comprehensive report that is delivered to the patient within 3 to 4 weeks.
This test is valuable in confirming a diagnosis of Fabry disease for individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of Fabry disease or for prenatal testing in families with a known GLA gene mutation. It is crucial to note that genetic testing for Fabry disease should always be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and guidance.
| Test Name | GLA Gene Fabry disease Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GLA Gene Fabry disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Fabry disease |
| Test Details |
The GLA gene Fabry disease NGS genetic test is a diagnostic test used to identify mutations in the GLA gene associated with Fabry disease. Fabry disease is a rare genetic disorder characterized by the buildup of a fatty substance called globotriaosylceramide (GL-3) in various tissues and organs, leading to a range of symptoms. Next-generation sequencing (NGS) technology is used in this test to analyze the DNA sequence of the GLA gene. This allows for the detection of mutations or variations in the gene that may be responsible for causing Fabry disease. NGS is a high-throughput sequencing method that can analyze multiple genes simultaneously, providing a comprehensive and efficient approach to genetic testing. The GLA gene Fabry disease NGS genetic test is typically performed on a blood or saliva sample. The sample is sent to a specialized laboratory where the DNA is extracted and sequenced using NGS technology. The resulting DNA sequence data is then analyzed, and any mutations or variations in the GLA gene are identified and reported. This test can be helpful in confirming a diagnosis of Fabry disease in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of Fabry disease or for prenatal testing in families with a known GLA gene mutation. It is important to note that genetic testing for Fabry disease should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and guidance. |
